About the Company
led by an experienced antiviral drug development team, chimerix is developing novel oral antiviral therapeutics with the potential to improve quality of life for patients in multiple settings, including transplant, oncology, acute care and global health. the company’s proprietary lipid technology has given rise to two clinical stage compounds, cmx001 and cmx157, which have demonstrated the potential for enhanced activity, bioavailability and safety compared to currently approved drugs. chimerix’s lead compound, cmx001, is a broad spectrum lipid acyclic nucleoside phosphonate that inhibits double-stranded dna (dsdna) viruses including cytomegalovirus (cmv), adenovirus, bk virus, herpes simplex virus and variola (smallpox). cmx001 has completed phase 2 clinical development for the prophylaxis of cmv and is in phase 2 development for the preemption and treatment of adenovirus infection in hematopoietic stem cell transplant (hsct) recipients. to date, more than 750 patients have been dosed
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $CMRX News
Chimerix, Inc. (NASDAQ:CMRX) Q4 2023 Earnings Call Transcript
February 29, 2024 Chimerix, Inc. beats earnings expectations. Reported EPS is $-0.2, expectations were $-0.23. CMRX isn't one ...
Chimerix Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
Revenue missed analyst estimates by 14%. Earnings per share (EPS) exceeded analyst estimates by 2.1%. Looking ahead, revenue ...
CMRX Apr 2024 1.000 put
Chimerix ( NASDAQ:CMRX ) Full Year 2023 Results Key Financial Results Net loss: US$82.1m (down by 148% from US$172.2m... Chimerix, Inc. (NASDAQ:CMRX) Q4 2023 Earnings Call Transcript February 29, 2024 ...
Rare Stock Picks In February 2024 - From 32 Discerning Analysts
Rare Stock Picks series, we're highlighting February 2024 investment picks. Click here for the list of February 2024 Buy ...
Defense Sec. defends his secret absence
Defense Secretary Lloyd Austin squared off with the House lawmakers Thursday about his secret hospital stay, following complications from prostate cancer surgery.
Loading the latest forecasts...